We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




First of Its Kind Multi-Stage Drug-Coated Balloon Technology to Help Fight GI Stenosis

By HospiMedica International staff writers
Posted on 09 Jun 2023
Print article
Image: ProTractX3 TTS DCB has been granted US FDA’s breakthrough device designation (Photo courtesy of GIE Medical)
Image: ProTractX3 TTS DCB has been granted US FDA’s breakthrough device designation (Photo courtesy of GIE Medical)

For decades, the approach to treating gastrointestinal (GI) strictures has remained largely unchanged. Now, an innovative technology offers a potential breakthrough in treating individuals with challenging GI strictures, leading to simpler, more cost-effective, and less invasive patient care.

GIE Medical (Brooklyn Park, MN, USA) has developed ProTractX3 TTS DCB for the dilation of recurring benign esophageal strictures in adult patients. These strictures, linked to the narrowing of the esophagus, cause obstructive symptoms in such patients. The ProTractX3 3-Stage TTS DCB is a balloon coated with the chemotherapeutic agent paclitaxel. This drug-coated balloon (DCB), deployable through the scope, presents a novel solution for GI stricture treatment, potentially ensuring long-term sustained patency and reducing the need for multiple treatments.

In December 2022, GIE Medical initiated two extensive, multicenter randomized controlled clinical trials in the United States. These trials are designed to examine the performance of the company's pioneering multi-stage DCB technology, ProTractX3 TTS DCB. The FDA Center for Devices and Radiological Health (CDRH) has awarded GIE Medical the Breakthrough Device Designation to speed up the development of its ProTractX3 TTS DCB. This designation is granted as the device shows significant potential to offer a more effective treatment or diagnosis for life-threatening or irreversibly debilitating diseases or conditions compared to the existing standard of care.

"We are honored to have our drug-coated balloon catheters selected for the FDA's Breakthrough Device Program for esophageal strictures. This may provide U.S. patients faster access to our novel DCB technology, with the potential to provide safer and more effective treatment," said Lixiao Wang, chairman and CEO of GIE Medical. "This designation will give U.S. gastrointestinal physicians exciting new tools to fight GI stenosis."

Related Links:
GIE Medical

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Bronchoscopy Head Support
Reison 10-330

Print article

Channels

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.